Aetna at Crossroads: Can Karen Lynch Lead the Company Back to Health?
| Case Code: LDEN225 Case Length: 20 Pages Period: 2000-2024 Pub Date: 2025 Teaching Note: Available |
Price: Rs.400 Organization : Aetna Inc. Industry :Pharmaceuticals & Biotech Countries : United States Themes: Strategic Leadership, Stakeholder Management, Crisis Management,Strategic Planning |
Abstract Case Intro 1 Case Intro 2 Excerpts
Introduction
In mid-2024, a financial report revealed that Aetna, the insurance division of CVS Health Corporation (CVS Health), a US based healthcare company, was facing serious issues. On August 09, 2024, Karen Lynch stated “I have decided to make leadership changes effective immediately.” Aetna’s operating income was reported to have decreased by 39% to $938 million while the net income had witnessed a 9% year-over-year drop to $1.77 billion in the second quarter of 2024 compared to same quarter in 2023.
In September 2023, Lynch had made the decision to replace Aetna’s president Brian Kane (Kane), who had been appointed only a year earlier . Lynch had previously served as Aetna’s president – from 2015 to 2021 – before assuming the role of chief executive officer (CEO) at CVS Health that had acquired Aetna in November 2018. Lynch would now oversee the insurer’s operations alongside CFO Tom Cowhey...
Buy this case study (Please select any one of the payment options)
| Price: Rs.400 |
Price: Rs.400 | PayPal (9 USD) |
